Which of the following is NOT a requirement for selling a Class A opioid in Saskatchewan?

Selling a Class A opioid in Saskatchewan involves several regulatory requirements designed to ensure safe dispensing and patient awareness. Among these requirements, electronic tracking of sales is not mandated. This means that while pharmacies may employ electronic systems to track the sale of medications for their own records or to comply with broader regulations, there is no specific legal obligation to utilize such electronic tracking for Class A opioids.

In contrast, packaging with a warning sticker, providing patient information handouts, and ensuring that opioids are administered under supervision are all critical components of the regulatory framework. These measures serve to provide essential information and safety guidance to patients, thereby reducing the risk of misuse or adverse effects associated with opioid medications.

Ensuring proper packaging and information helps inform patients about their medications while administering under supervision aligns with the goal of promoting responsible use. Thus, options A, B, and D align with the legal requirements, distinguishing them from the correct answer regarding electronic tracking.